Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1432, Issue 1, 1999, Pages 27-39

  Dalpiaz, Alessandro ^a   Ferretti, Maria E ^b   Pecoraro, Rita ^a   Fabbri, Elena ^c   Traniello, Serena ^a   Scatturin, Angelo ^a   Spisani, Susanna ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Department of Biology   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antagonist; Cytosolic calcium; Formyl peptide receptor; Human neutrophil; Neutrophil functionality

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR ANTAGONIST; PENTAPEPTIDE; PHENYLALANINE DERIVATIVE; PHENYLALANYLLEUCYLPHENYLALANYLLEUCYLPHENYLALANINE DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CHEMOTAXIS; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; NEUTROPHIL; NORMAL HUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

BINDING, COMPETITIVE; CALCIUM; CIRCULAR DICHROISM; HUMANS; MOLECULAR STRUCTURE; MURAMIDASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OLIGOPEPTIDES; PROTEIN CONFORMATION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUPEROXIDES;

EID: 0033061847     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(99)00081-3     Document Type: Article

References (45)

1. Marasco W.A., Phan S.H., Krutzsch H., Showell H.J., Feltner D.E., Nairn R., Becker E.L., Ward P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:1984;5430-5439.
2. Rot A., Henderson L.E., Copeland T.D., Leonard E.J. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy. Proc. Natl. Acad. Sci. USA. 84:1987;7967-7971.
3. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 185:1982;264-275.
4. Prossnitz E.R., Ye R.D. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:1997;73-102.
5. August J.T., Anders M.W., Murad F., Coyle J. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39:1997;221-289.
6. Koo C., Lefkowitz J., Snyderman R. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem. Biophys. Res. Commun. 106:1982;442-449.
7. Koo C., Lefkowitz J., Snyderman R. Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. J. Clin. Invest. 72:1983;748-753.
8. 2+ control of formyl-peptide-receptor-G-protein interaction in HL 60 cells. Eur. J. Biochem. 183:1989;97-105.
9. Bouley F., Tardif M., Brouchon L., Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 29:1990;11123-11133.
10. Prossnitz E.R., Schreiber R.E., Bokoch G.M., Ye R.D. Binding of low affinity N-formyl peptide receptors to G protein. J. Biol. Chem. 270:1995;10686-10694.
11. Freer R.J., Day A.R., Radding J.A., Schiffman E., Aswanikumar S., Showell H.J., Becker E.L. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry. 19:1980;2404-2410.
12. Freer R.J., Day A.R., Muthukumaraswamy N., Pinon D., Wu A., Showell H.J., Becker E.L. Peptide chemoattractants: a model of the receptor rabbit neutrophils. Biochemistry. 21:1982;257-263.
13. Derian K., Solomon H.F., Higgins J.D., Beblavy J.M., Santulli R.J., Bridger G.J., Pike M.C., Kroon D.J., Fishman A.J. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemistry. 35:1996;1265-1269.
14. Iqbal M., Balaram P., Showell H.J., Freer R.J., Becker E.L. Conformationally constrained chemotactic peptide analogs of high biological activity. FEBS Lett. 165:1984;171-174.
15. Dentino A.W., Periathamby A.R., De Nardin E. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides. Arch. Biochem. Biophys. 337:1997;267-274.
16. Dentino A.W., Periathamby A.R., Bhandary K.K., Wilson M.E., Levine M.J. Role of peptide backbone conformation on biological activity of chemotactic peptides. J. Biol. Chem. 226:1991;18460-18468.
17. Spisani S., Cavalletti T., Gavioli R., Scatturin A., Vertuani G., Traniello S. Response of human neutrophils to formyl-peptide modified at the terminal amino and carboxyl groups. Inflammation. 10:1986;363-369.
18. Higgins J.D., Bridger G.J., Derian C.K., Beblavy M.J., Hernandez P.E., Gaul F.E., Abrams M.J., Pike M.C., Solomon H.F. N-Terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 39:1996;1013-1015.
19. S. Aswanikumar, B.A. Corcoran, E. Schiffman, Peptides with agonist and antagonist chemotactic activity, in: M. Goodman, J. Meinhofer (Eds.), Peptides, Wiley and Sons, New York, 1977, pp. 141-145.
20. Day A., Pinon D., Muthukumaraswamy N., Freer R.J. Synthesis of several chemotactic peptide antagonists. Peptides. 1:1980;289-291.
21. R.J. Freer, A.R. Day, E.L. Becker, H.J. Showell, E. Schiffmann, E. Gross, Chemotactic peptides as probes of molecular events in leukocytes chemotaxis, in: E. Gross, J. Meinhofer (Eds.), Peptides, Wiley and Sons, New York, 1979, pp. 749-751.
22. Schifmann E., Aswanikumar S., Venkatasubramanian K., Corcoran B.A., Pert C.B., Brown J., Gross E., Day A.R., Freer R.J., Showell A.H., Becker E.L. Some characteristics of the neutrophil receptor for chemotactic peptides. FEBS Lett. 117:1980;1-7.
23. E. Schifmann, K. Venkatasubramanian, B. Corcoran, S. Aswanikumar, A.R. Day, R.J. Freer, I.J. Gallin, F. Hirata, R.A. Clark, J.H. Brown, E. Gross, Chemotactic peptides as probes of molecular events in leukocyte chemotaxis, in: E. Gross, J. Meinhofer (Eds.), Peptides, Wiley and Sons, New York, 1979, pp. 731-741.
24. n peptides as agonists and antagonists of the chemotactic formylpeptide receptor of the rabbit peritoneal neutrophil. Biochim. Biophys. Acta. 1034:1990;67-72.
25. Moroder L., Hallet A., Wunsch E., Keller O., Wersin G., Hoppe Seyler's Z. Di-tert.-butyldicarbonat - ein vorteilhaftes Reagenz zur Einführung der tert.-Butyloxycarbonyl-Schutzgruppe. Physiol Chem. 357:1976;1651-1653.
26. Takeda K., Akagi T., Saiki A., Tsukahara T., Ogura A. Convenient method for synthesis of active carbamates, ureas and nitrosoureas using N,N DSC. Tetrahedron Lett. 24:1983;4568-4572.
27. Schippers P.H., Dekkers H.P. Direct determination of absolute circular dichroism data and calibration of commercial instruments. Anal. Chem. 53:1981;778-782.
28. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
29. 2+. Biochim. Biophys. Acta. 1359:1997;233-240.
30. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3445.
31. Zigmond S.H., Hirsch J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:1973;387-391.
32. 6c-Phe-OMe. Biopolymers. 39:1996;327-332.
33. Urry D.W. Protein conformation in biomembranes: optical rotation and absorption of membrane suspensions. Biochim. Biophys. Acta. 265:1972;115-168.
34. Rajan R., Balaram P. A model for the interaction of trifluoroethanol with peptides and proteins. Int. J. Peptide Protein Res. 48:1996;328-337.
35. Kitagawa O., Van der Velde D., Dutta D., Morton M., Takusagawa F., Aubé J. Structural analysis of β-turn mimics containing a substituted 6-aminocaproic acid linker. J. Am. Chem. Soc. 19:1995;5169-5178.
36. Crisma M., Fasman G.D., Balaram H., Balaram P. Peptide models of β-turns. Int. J. Peptide Protein Res. 23:1984;411-419.
37. Chang C.T., Wu C.S.C., Yang J.T. Circular dichroic analysis of protein conformation: inclusion of the β-turns. Anal. Biochem. 91:1978;13-31.
38. 3 analog of the formyl methionyl tripeptide chemoattractant. Peptide Res. 4:1991;66-71.
39. Surewicz W.K., Mantsch H.H. New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochim. Biophys. Acta. 952:1988;115-130.
40. P. Taylor, P.A. Insel, Molecular basis of pharmacologic selectivity, in: W.B. Pratt, P. Taylor (Eds.), Principles of Drug Action, Churchill Livingstone, New York, 1990, pp. 1-102.
41. 2a receptor ligands. Biochem. Pharmacol. 49:1995;461-469.
42. Spisani S., Breveglieri A., Reali E., Scatturin A., Vertuani G., Cavicchioni G. Biological properties of the fMLP analog containing an iodomethylated methionine residue. Protein Peptide Lett. 2:1995;415-418.
43. Iizawa O., Akamatsu H., Niwa Y. Neutrophil chemotaxis, phagocytosis and generation of reactive oxygen species show a hierarchy of responsiveness to increasing concentrations of N-Formyl-Met-Leu-Phe. Biol. Signals. 4:1995;14-18.
44. Lagant P., Vergoten G., Fleury G., Loucheux-Lefebvre M.H. Vibrational normal modes of folded prolyl-containing peptides. Eur. J. Biochem. 139:1984;149-154.
45. Schreiber R.E., Prossnitz E.R., Ye R.D., Cochrane C.G., Bokoch G.M. Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. J. Biol. Chem. 269:1994;326-331.